Phase 3b/4 Safety Trial of Nivolumab Combined with Ipilmumab in Subjects with Previously Untreated, Advanced or Metastatic RCC

Administered By

Awarded By

Contributors

Start/End

  • January 25, 2018 - July 15, 2021